Literature DB >> 30518783

Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1.

Tiancheng Zhao1, Yahong Chen2, Shihou Sheng3, Yuanyu Wu2, Tao Zhang2.   

Abstract

This study aimed to analyze the functions of microRNA 498 (miR-498) on gastric cancer (GC) cell proliferation migration and cisplatin chemosensitivity. QTR-PCR found that miR-498 was markedly downregulated in GC cell lines and human GC tumors. It was discover that, lentivirus-mediated miR-498 overexpression inhibited cancer cell proliferations in vitro and in vivo, invasion and cisplatin chemoresistance. Bmi1 was demonstrated to be directly regulated by miR-498 in GC cell lines. Moreover, Bmi1 upregulation was found to reverse the tumor-suppressing functions of miR-498 in GC. Therefore, this study presented evidence showing miR-498 expression decreased in GC, and overexpressing miR-498 had significant inhibitory effects on GC development, likely through the inverse interaction of Bmi1.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30518783     DOI: 10.1038/s41417-018-0065-7

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  3 in total

1.  MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression.

Authors:  Mingxi Wang; Qiang Zhang; Junbin Wang; Yunzhi Zhai
Journal:  J Cancer Res Ther       Date:  2015-08       Impact factor: 1.805

2.  Low miR-498 expression levels are associated with poor prognosis in ovarian cancer.

Authors:  J Cong; R Liu; X Wang; J Wang; H Wang; J Hou
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-12       Impact factor: 3.507

3.  Endocan silencing induces programmed cell death in hepatocarcinoma.

Authors:  Jinghui Yang; Shihou Sheng; Qiwei Yang; Li Li; Shaoyou Qin; Shan Yu; Xuewen Zhang
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

  3 in total
  8 in total

Review 1.  Non-coding RNAs underlying chemoresistance in gastric cancer.

Authors:  Arash Poursheikhani; Zahra Bahmanpour; Ehsan Razmara; Ladan Mashouri; Mohammad Taheri; Dorsa Morshedi Rad; Hassan Yousefi; Amirreza Bitaraf; Sadegh Babashah
Journal:  Cell Oncol (Dordr)       Date:  2020-06-03       Impact factor: 6.730

2.  LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1.

Authors:  Jun Fang; Wei Chen; Xiang-Ling Meng
Journal:  Pathol Oncol Res       Date:  2019-10-22       Impact factor: 3.201

3.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

4.  MicroRNA-498 inhibits the proliferation, migration and invasion of gastric cancer through targeting BMI-1 and suppressing AKT pathway.

Authors:  Dong You; Dawei Wang; Peiji Liu; Yuning Chu; Xueying Zhang; Xueli Ding; Xiaoyu Li; Tao Mao; Xue Jing; Zibin Tian; Yinghua Pan
Journal:  Hum Cell       Date:  2020-02-13       Impact factor: 4.374

5.  Propofol suppresses hypoxia-induced esophageal cancer cell migration, invasion, and EMT through regulating lncRNA TMPO-AS1/miR-498 axis.

Authors:  Meng Gao; Rui Guo; Xihua Lu; Gang Xu; Suxia Luo
Journal:  Thorac Cancer       Date:  2020-07-08       Impact factor: 3.500

6.  DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.

Authors:  Meng Cao; Peng-Bo Zhang; Peng-Fei Wu; Qun Chen; Wan-Li Ge; Guo-Dong Shi; Jie Yin; Bao-Bao Cai; Shou-Ji Cao; Yi Miao; Kui-Rong Jiang
Journal:  Biomed Res Int       Date:  2021-03-02       Impact factor: 3.411

7.  CircPDZD8 promotes gastric cancer progression by regulating CHD9 via sponging miR-197-5p.

Authors:  Tianfang Xia; Zhenguo Pan; Jie Zhang
Journal:  Aging (Albany NY)       Date:  2020-10-13       Impact factor: 5.682

Review 8.  Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role.

Authors:  Elena Gallardo Martin; Antia Cousillas Castiñeiras
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.